Your institution may have access to this item. Find your institution then sign in to continue.
Title
Drug & therapeutics update.
Abstract
The article discusses the availability of new therapeutic products indicated for oncology, the kinase inhibitor Iclusig tablet from Ariad Pharmaceuticals Inc., the CYP17 inhibitor Zytiga tablet from Janssen Biotech Inc. and the angiogensis inhibitor Avastin from Genentech U.S. Inc.